Celldex to Present at the 2022 Jefferies Global Healthcare Conference
Celldex Therapeutics (NASDAQ:CLDX) announced that its senior management will participate in a fireside chat at the 2022 Jefferies Global Healthcare Conference on June 8, 2022, at 8:30 a.m. ET in New York City. This event will provide insights into the company's advancements in monoclonal and bispecific antibodies aimed at treating severe diseases.
A webcast of the presentation will be accessible on the Investors & Media section of the Celldex website, with a replay available for 30 days afterward.
- None.
- None.
HAMPTON, N.J., June 06, 2022 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that senior management will participate in a fireside chat at the 2022 Jefferies Global Healthcare Conference in New York City on Wednesday, June 8, 2022 at 8:30 a.m. ET.
A webcast of the presentation will be available on the "Events & Presentations" page of the "Investors & Media" section of the Celldex website. A replay will be available for 30 days following the event.
About Celldex Therapeutics, Inc.
Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer. Visit www.celldex.com.
Company Contact
Sarah Cavanaugh
Senior Vice President, Corporate Affairs & Administration
(508) 864-8337
scavanaugh@celldex.com
Patrick Till
Senior Director, Investor Relations & Corporate Communications
(484) 788-8560
ptill@celldex.com
FAQ
When will Celldex Therapeutics participate in the Jefferies Global Healthcare Conference?
How can I watch the Celldex Therapeutics presentation at the conference?
What is the main focus of Celldex Therapeutics?